{"name":"Aphios","slug":"aphios","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APH-1105","genericName":"APH-1105","slug":"aph-1105","indication":"Other","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"APH-1501","genericName":"APH-1501","slug":"aph-1501","indication":"Treatment-resistant epilepsy","status":"phase_2"}]}],"pipeline":[{"name":"APH-1105","genericName":"APH-1105","slug":"aph-1105","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"APH-1501","genericName":"APH-1501","slug":"aph-1501","phase":"phase_2","mechanism":"APH-1501 is a cannabinoid-based therapy.","indications":["Treatment-resistant epilepsy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPMl9rVWxOSmZxRHowVGdVOF9CVDBfcnRfWWdsNWJWVkIyNEI4czZIOEVVcXFGUHd0TWFFWHdZeUxfWXZ4VUZncF9KM3IybHNad21HblYwTzJLTGc4S0FMbTVpSjU3bEU1R1FpNU8yOElyWXBFTGFFQThYTG41cEp6QzhJbXg3S3JSNXF4ZVJ4RWdyUjlqSGJScW80WmNhM09l?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Opioid Use Disorder Clinical Trial Pipeline Appears Robust With - openPR.com","headline":"Opioid Use Disorder Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNelRlX1ZBZE1uajZBcjIzY3lySmktancxUGFCWlZJMFFkc1VuS1dXUmRwZlZVRGg0UlJGMm54WXAyOVVWR1RUM0oyOW9RNXEzbW9VUF9GLTJ4SXp0aTZFX29yYkUyZEF5V1JPZkR4YmJTdUFjYXpUVkJvM3JKWi1weElmQkE0YjE1LUJ4MURkNk9rY0ViUVd6ZkZGOWYxUQ?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Leading Companies Reinforcing Their Presence in the Liposomal Drug Delivery Devices Market - openPR.com","headline":"Leading Companies Reinforcing Their Presence in the Liposomal Drug Delivery Devices Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPUGN3UEZFeFdybDdqdUplVWtmUkx2UTI0Ymk1LVc4dkxMT0ExazFVN1JVVU9wZDA3M2JHRXVvVmEzMUhCTDFNSEJXelN0UW1ydmdZMFpNdXc4UVdFWVUxQ0ZTbm9ha3lOekY0OUJfWE9ucFVUNVZhMU5qZGY0ZXQyZ0MxNXdORGdsa2FNZWNQdEZqR19OZVpIZGpCVTFDTWVrXzk4QnpFSjk0ZGtXMDhOMF9PZUJRSG5SWFpmcnpXMEczLXE2R2txQmtRT09LaTFud2Z1dkZlRl8wazBiV05seUJaRUN6LXhnTUNWZzdycw?oc=5","date":"2025-10-08","type":"pipeline","source":"BioSpace","summary":"Aphios Corporation Awarded NIH Grant to Advance Botanical Drug Zindol® for Cancer Treatment Related Nausea and Vomiting - BioSpace","headline":"Aphios Corporation Awarded NIH Grant to Advance Botanical Drug Zindol® for Cancer Treatment Related Nausea and Vomiting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOX0tWV1VaVnlYcXVwVnNxa1o0cDZ6eHQwMDR6VUUzTE9UdlFPVVhKMkFxRTNDUTA4bWo5UnFid0hLaHh2bVpDaGJvbHFTakpsSTF4TUFTSEkwOF9EV215M0d6REs3clN6UHQwZ0Q2bWtxM3Y0VkhSRUxtYVoxbEFweUg3WnYweGNmenkyM21jeGNhcFpQcm1BOWxnNF9LeTNyaFNtZDRFWWFKRUNXbk1hMnFJYkZuWHl5Zk1fSERRcXBoWnpfVFBDR2M1dVNrXy1IMkdzcGFtdzdvWGdWSnY2M0tHWWo5WFVwVG9PZjRwWldZbWt6aFFHUVlVek0yWHBCZUV2UHpmcEI5N0syUXRyT1A2ckpOdmc?oc=5","date":"2025-08-07","type":"trial","source":"GlobeNewswire","summary":"Cancer Cachexia Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"Cancer Cachexia Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPbFdMcXBXWG43UDBlLUtCX1R0ZmtZSVNEYzVUVWJWYmllakVJS0dMYkJwVXJ3MXFoRldWZDFqV1lTS0I2Qm5aWEppVFZxX0U5OVI5bWNGQVg2eXYtWjczWVpLd2FYUjREUm1wS2NyeGJ5R1VodWg3eUVxTnlzRFNoVXdEdndsSU81RVduZFowbHBNZF9KY0pjYU1DWC1HX3VVV3lZcm4zTHVSYWJ0UHJxa1dRV0g2bFFVOUxmaWd4QzVDR1AyLURPcllZMTJEa3ppOGNQUGZIZkloQUk2T3JubFFGWTFYQQ?oc=5","date":"2025-01-15","type":"patent","source":"Business Wire","summary":"Aphios Granted US Patent for Thermal Conversion of CBDA and Other Carboxylic Acid Cannabinoids - Business Wire","headline":"Aphios Granted US Patent for Thermal Conversion of CBDA and Other Carboxylic Acid Cannabinoids","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}